三维适形放疗局部晚期非小细胞肺癌的放射性肺炎风险因素研究

被引:48
作者
朱向帜
王绿化
王颖杰
姬巍
王小震
张莉
曹建中
章众
张可
殷蔚伯
机构
[1] 中国医学科学院中国协和医科大学肿瘤医院肿瘤研究所放疗科
关键词
非小细胞肺癌/三维适形放射疗法; 剂量体积直方图; 放射性肺炎;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100117 [系统生物医学];
摘要
目的分析三维适形放疗(3DCRT)的ⅢA和ⅢB期非小细胞肺癌病例,分别评估≥2、3级放射性肺炎的发生与临床及剂量学参数的关系。方法107例病理组织学证实的ⅢA、ⅢB期非小细胞肺癌接受了平均60(26-74)Gy的3DCRT,其中42例单纯放疗,65例序贯放化疗。记录各临床因素及剂量体积直方图(DVH)参数,观察放疗结束3个月内发生的≥2级放射性肺炎(RP)和≥3级的放射性肺炎(SRP)。分级采用NCICTC3.0标准,统计用SPSS10.0软件包。结果107例共发生放射性肺炎39例,其中2级26例,3级10例,5级3例,SRP标准的13例。对RP单因素分析显示MLD、IMLD、CMLD、IV20-IV35、CV10、CV15、CV40、CV50及V10-V35有统计学意义(P=0.004、0.009、0.047、0.010、0.008、0.014、0.031、0.022、0.016、0.023、0.026、0.048、0.006、0.002、0.027、0.032、0.043),多因素分析显示V20是惟一RP发生的预测因子(P=0.005)。对SRP单因素分析显示MLD、IV20、IV25、IV30、CV5、CV10、V10、V15、V20、V30有统计学意义(P=0.005),多因素分析显示CV10是惟一SRP发生的预测因子(P=0.028)。结论对Ⅲ期非小细胞肺癌3DCRT,DVH参数与放射性肺炎的发生明显相关,其中V20、CV10分别是预测RP、SRP的剂量学指标。
引用
收藏
页码:421 / 426
页数:6
相关论文
共 14 条
[1]
Correlation of dosimetric factors and radiation pneumonitis for non–small-cell lung cancer patients in a recently completed dose escalation study.[J].Ellen D. Yorke;Andrew Jackson;Kenneth E. Rosenzweig;Louise Braban;Steven A. Leibel;C. Clifton Ling.International Journal of Radiation Oncology; Biology; Physics.2005, 3
[2]
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy [J].
Fay, M ;
Tan, A ;
Fisher, R ;
Mac Manus, M ;
Wirth, A ;
Ball, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1355-1363
[3]
Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma.[J].Jeffrey Bradley;Mary V. Graham;Kathryn Winter;James A. Purdy;Ritsuko Komaki;Wilson H. Roa;Janice K. Ryu;Walter Bosch;Bahman Emami.International Journal of Radiation Oncology; Biology; Physics.2005, 2
[4]
Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review.[J].George Rodrigues;Michael Lock;David D'Souza;Edward Yu;Jake Van Dyk.Radiotherapy and Oncology.2004, 2
[5]
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer [J].
Tsujino, K ;
Hirota, S ;
Endo, M ;
Obayashi, K ;
Kotani, Y ;
Satouchi, M ;
Kado, T ;
Takada, Y .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01) :110-115
[6]
Comparing different NTCP models that predict the incidence of radiation pneumonitis [J].
Seppenwoolde, Y ;
Lebesque, JV ;
de Jaeger, K ;
Belderbos, JSA ;
Boersma, LJ ;
Schilstra, C ;
Henning, GT ;
Hayman, JA ;
Martel, MK ;
Ten Haken, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (03) :724-735
[7]
Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis [J].
Onishi, H ;
Kuriyama, K ;
Yamaguchi, M ;
Komiyama, T ;
Tanaka, S ;
Araki, T ;
Nishikawa, K ;
Ishihara, H .
LUNG CANCER, 2003, 40 (01) :79-84
[8]
Dosis-Volumen-Histogramm-Analyse zum Pneumonitisrisiko bei 3-D-konformaler Strahlentherapie im Bereich der Lunge.[J].Jochen Willner;Andre Jost;Kurt Baier;Michael Flentje.Strahlentherapie und Onkologie.2003, 8
[9]
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy [J].
Yorke, ED ;
Jackson, A ;
Rosenzweig, KE ;
Merrick, SA ;
Gabrys, D ;
Venkatraman, ES ;
Burman, CM ;
Leibel, SA ;
Ling, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :329-339
[10]
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β [J].
Fu, XL ;
Huang, H ;
Bentel, G ;
Clough, R ;
Jirtle, RL ;
Kong, FM ;
Marks, LB ;
Anscher, MS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :899-908